公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2014 | IPSS-R in 555 Taiwanese patients with primary MDS: Integration of monosomal karyotype can better risk-stratify the patients | YI-TSUNG YANG ; HSIN-AN HOU ; Liu C.-Y.; CHIEN-CHIN LIN ; WEN-CHIEN CHOU ; Lee F.-Y.; Liu M.-C.; Liu C.-W.; JIH-LUH TANG ; MING YAO ; Li C.-C.; Kuo Y.-Y.; SHANG-YI HUANG ; BOR-SHENG KO ; Chen, Chien-Yuan ; SZU-CHUN HSU ; Lin C.-T.; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | American Journal of Hematology | 19 | 16 | |
2022 | Iptacopan monotherapy in patients with paroxysmal nocturnal hemoglobinuria: a 2-cohort open-label proof-of-concept study | Jang, Jun Ho; Wong, Lily; BOR-SHENG KO ; Yoon, Sung-Soo; Li, Katie; Baltcheva, Irina; Nidamarthy, Prasanna Kumar; Chawla, Raghav; Junge, Guido; Yap, Eng Soo | Blood advances | 15 | 11 | |
2005 | Isolation of multipotent cells from human term placenta | Yen B.L.; Huang H.-I.; Chien C.-C.; Jui H.-Y.; BOR-SHENG KO ; MING YAO ; CHIA-TUNG SHUN ; MEN-LUH YEN ; Lee M.-C.; YAO-CHANG CHEN | Stem Cells | 409 | 336 | |
2012 | A Knock-In Npm1 Mutation in Mice Results in Myeloproliferation and Implies a Perturbation in Hematopoietic Microenvironment | Chou S.-H.; BOR-SHENG KO ; Chiou J.-S.; Hsu Y.-C.; MONG-HSUN TSAI ; Chiu Y.-C.; Yu I.-S.; SHU-WHA LIN ; HSIN-AN HOU ; Kuo Y.-Y.; Lin H.-M.; Wu M.-F.; WEN-CHIEN CHOU ; HWEI-FANG TIEN | PLoS ONE | 20 | 17 | |
2020 | A Knowledge-Reserved Distillation with Complementary Transfer for Automated FC-based Classification Across Hematological Malignancies | Li J.-L.; Chang T.-Y.; Wang Y.-F.; BOR-SHENG KO ; JIH-LUH TANG ; Lee C.-C. | Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBS | 1 | 0 | |
2019 | Learning a Cytometric Deep Phenotype Embedding for Automatic Hematological Malignancies Classification | Li J.-L.; Wang Y.-F.; BOR-SHENG KO ; Li C.-C.; JIH-LUH TANG ; Lee C.-C. | Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBS | 5 | 0 | |
2019 | Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome | HUAI-HSUAN HUANG ; Chen F.-Y.; WEN-CHIEN CHOU ; HSIN-AN HOU ; BOR-SHENG KO ; Lin C.-T.; JIH-LUH TANG ; Li C.-C.; MING YAO ; WOEI TSAY ; SZU-CHUN HSU ; SHANG-JU WU ; Chen, Chien-Yuan ; SHANG-YI HUANG ; Tseng M.-H.; HWEI-FANG TIEN ; Chen R.-H. | BMC Cancer | 41 | 34 | |
2009 | Long-term outcome of allogeneic human leukocyte antigen-matched sibling-donor peripheral blood stem cell transplantation in leukaemia patients | JIH-LUH TANG ; MING YAO ; MENG-YAO LU ; BOR-SHENG KO ; Lin D.T.; KAI-HSIN LIN ; YEN-CHING CHEN | Hong Kong Medical Journal | 1 | 0 | |
2019 | Long-term safety and efficacy of deferasirox in patients with myelodysplastic syndrome, aplastic anemia and other rare anemia in Taiwan | BOR-SHENG KO ; Chang M.-C.; Chiou T.-J.; Chang T.-K.; Chen Y.-C.; Lin S.-F.; Chang C.-S.; Lu Y.-C.; Yeh S.-P.; Chen T.-Y.; Hwang W.-S. | Hematology (United Kingdom) | 5 | 4 | |
2007 | Lymph nodes in gastrointestinal tract | TSUNG-CHUN LEE ; BOR-SHENG KO ; CHIA-TUNG SHUN ; Lin J.-T.; Spiller R.; HSIU-PO WANG | Gut | 0 | 0 | |
2023 | Lysosomal-targeted doxorubicin delivery using RBC-derived vesicles to overcome drug-resistant cancer through mitochondrial-dependent cell death | CHIH-PENG LIN ; Wu, Shu-Hui; Lin, Tzu-Yin; Chu, Chia-Hui; Lo, Leu-Wei; Kuo, Ching-Chuan; Chang, Jang-Yang; SZU-CHUN HSU ; BOR-SHENG KO ; MING YAO ; Hsiao, Jong-Kai; Wang, Shih-Wei; Huang, Dong-Ming | Pharmacological research | 0 | 0 | |
2022 | A Machine Learning Approach to the Classification of Acute Leukemias and Distinction From Nonneoplastic Cytopenias Using Flow Cytometry Data | Monaghan S.A.; Li J.-L.; Liu Y.-C.; Ko M.-Y.; Boyiadzis M.; Chang T.-Y.; Wang Y.-F.; Lee C.-C.; Swerdlow S.H.; BOR-SHENG KO | American Journal of Clinical Pathology | 12 | 4 | |
2022 | Outcomes of Different Haploidentical Transplantation Strategies from the Taiwan Blood and Marrow Transplantation Registry | CHENG-HONG TSAI ; Chen, Tzu-Ting; Gau, Jyh-Pyng; Wang, Po-Nan; Liu, Yi-Chang; Lien, Ming-Yu; Li, Chi-Cheng; MING YAO ; BOR-SHENG KO | Cancers | 5 | 4 | |
2009 | Overexpressed focal adhesion kinase predicts a higher incidence of extrahepatic metastasis and worse survival in hepatocellular carcinoma | Jan Y.-J.; BOR-SHENG KO ; CHIUN HSU ; Chang T.-C.; Chen S.-C.; Wang J.; Liou J.-Y. | Human Pathology | 28 | 27 | |
2011 | Overexpression of 14-3-3ε predicts tumour metastasis and poor survival in hepatocellular carcinoma | BOR-SHENG KO ; Chang T.-C.; CHIUN HSU ; YAO-CHANG CHEN ; Shen T.-L.; Chen S.-C.; Wang J.; Wu K.K.; Jan Y.-J.; Liou J.-Y. | Histopathology | 48 | 46 | |
2016 | Paracrine regulation of matrix metalloproteinases contributes to cancer cell invasion by hepatocellular carcinoma-secreted 14-3-3s | Liu C.-C.; Chang T.-C.; Lin Y.-T.; Yu Y.-L.; BOR-SHENG KO ; Sung L.-Y.; Liou J.-Y. | Oncotarget | 13 | 14 | |
2012 | Persistence of mutant isocitrate dehydrogenase in patients with acute myeloid leukemia in remission | WEN-CHIEN CHOU ; Peng K.-Y.; Lei W.-C.; BOR-SHENG KO ; WOEI TSAY ; CHING-HUA KUO ; HWEI-FANG TIEN | Leukemia | 20 | 19 | |
2001 | Philadelphia chromosome-positive acute lymphoblastic leukemia in Taiwan | BOR-SHENG KO ; JIH-LUH TANG ; Tsai W.; YAO-CHANG CHEN ; Wang C.-H.; Sheng M.-C.; Lin D.-T.; Lin K.-H.; HWEI-FANG TIEN | Annals of Hematology | 10 | 10 | |
2022 | Polatuzumab vedotin-based salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience | Wang, Yu-Wen; Tsai, Cheng-Hong ; HSIN-AN HOU ; FENG-MING TIEN ; JIA-HAU LIU ; WEN-CHIEN CHOU ; BOR-SHENG KO ; Chen, Yu-Wen; CHIEN-CHIN LIN ; Chieh-Lung Cheng ; Lo, Min-Yen; YUN-CHU LIN ; LI-CHUN LU ; SHANG-JU WU ; SUNG-HSIN KUO ; RUEY-LONG HONG ; TAI-CHUNG HUANG ; MING YAO | Annals of hematology | 10 | 9 | |
2021 | Pomalidomide and Dexamethasone Are Effective in Relapsed or Refractory Multiple Myeloma in a Real-Life Setting: A Multicenter Retrospective Study in Taiwan | Hung Y.-C.; Gau J.-P.; SHANG-YI HUANG ; BOR-SHENG KO ; Teng C.-L.J. | Frontiers in Oncology | 0 | 0 | |